Cargando…

YMDD motif mutation after lamivudine therapy

Detalles Bibliográficos
Autores principales:	Jazayeri, Seyed Mohammad, Miri, Seyed Mohammad, Alavian, Seyed Moayed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159254/ https://www.ncbi.nlm.nih.gov/pubmed/21897603 http://dx.doi.org/10.4103/0973-6247.83252

Ejemplares similares

YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy
por: Rahimi, Rahim, et al.
Publicado: (2015)

Appropriate Genotyping of Hepatitis B Virus in Iran
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2015)

Natural YMDD motif mutations in treatment naïve patients with chronic hepatitis B in Huzhou of eastern China
por: Qian, Fuchu, et al.
Publicado: (2016)

Occult Hepatitis B (OBH) in Clinical Settings
por: Alavian, Seyed Moayed, et al.
Publicado: (2012)

The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis
por: He, Min, et al.
Publicado: (2015)

Inflammation Pharmacological Reaction and YMDD Mutational Patterns in Lamivudine Therapeutics Hepatitis B Virus
por: Liu, Hongcan, et al.
Publicado: (2021)

Viral quasispecies of hepatitis B virus in patients with YMDD mutation and lamivudine resistance may not predict the efficacy of lamivudine/adefovir rescue therapy
por: Wang, Changtai, et al.
Publicado: (2019)

Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection
por: Ghandehari, Freshte, et al.
Publicado: (2011)

Detection of YMDD Motif Mutants by Oligonucleotide Chips in Lamivudine-Untreated Patients with Chronic Hepatitis B Virus Infection
por: Heo, Jeong, et al.
Publicado: (2004)

Epidemiology of Hepatitis B Virus Infection and the Main Risk Factors in Pakistan Needs More Attention
por: Alavian, Seyed Moayed
Publicado: (2011)

Hepatitis A in Developed Country, the Result Should Interpret Carefully
por: Alavian, Seyed-Moayed
Publicado: (2011)

Herbal medicine and liver disease, for any conclusion we need to do more studies
por: Alavian, Seyed Moayed
Publicado: (2011)

Hepatitis A virus vaccination in Iranian soldiers needs more attention
por: Alavian, Seyed Moayed
Publicado: (2016)

Occult Hepatitis B in Hemodialysis Patients is a Debate
por: Alavian, Seyed Moayed
Publicado: (2018)

Immigration and knowledge, education, and practices regarding chronic hepatitis B in pregnancy
por: Alavian, Seyed Moayed
Publicado: (2018)

Risk factors of hepatitis B infection: Health policy makers should be aware of their importance in each community
por: Miri, Seyed Mohammad, et al.
Publicado: (2011)

Dilemma of HBsAg seroconversion in chronic hepatitis B infection: Dilemma of HBsAg in chronic HBV
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

More Risk Factors of Hepatitis C Transmission Should be Considered in Pakistan
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Novel mutation in YMDD motif and direct neighbourhood in a child with chronic HBV-infection and clinical lamivudine and adefovir resistance - a scholarly case
por: Schildgen, Verena, et al.
Publicado: (2010)

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
por: Dindoost, Payam, et al.
Publicado: (2012)

Comments on Behavior of Healthcare Workers After Injuries From Sharp Instruments
por: Alavian, Seyed Moayed
Publicado: (2014)

Mutational analysis of reverse transcriptase and surface proteins of patients with partial virological response during mono and combination antiviral therapies in genotype D chronic hepatitis B
por: Mahabadi, Mostafa, et al.
Publicado: (2016)

letter to Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic Analysis of Hepatitis C Virus in Khuzestan Province, Southwestern Iran. Middle East J Dig Dis 2011;3:126-30
por: Alavian, Seyed Moayed, et al.
Publicado: (2012)

IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report
por: Mahboobi, Nastaran, et al.
Publicado: (2011)

Can We Accurately Assess Liver Fibrosis with Fibroscan® Using Fewer Valid Measurements?
por: Pournik, Omid, et al.
Publicado: (2013)

The Key Role of Non-governmental Organizations (NGOs) Activities in Viral Hepatitis Elimination Programs
por: Padami, Farzaneh, et al.
Publicado: (2018)

Vaccination in Health Care Workers Should be Following in our Country Now?!
por: Alavian, Seyed Moayed
Publicado: (2013)

Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran
por: Alavian, Seyed Moayed
Publicado: (2015)

Commentary on: A study of genotype, mutants and nucleotide sequence of HBV in Pakistan: Genotype, mutants, and nucleotide sequence of HBV
por: Jazayeri, Seyed Mohammad
Publicado: (2011)

Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study
por: Rezaee, Reza, et al.
Publicado: (2015)

The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis
por: Tan, Youwen, et al.
Publicado: (2012)

Detection of rtN236T mutation associated with adefovir dipivoxil resistance in Hepatitis B infected patients with YMDD mutations in Tehran
por: Monavari, Seyed Hamidreza, et al.
Publicado: (2013)

Letter to the Editor: The Increasing Hepatitis A Incidence in Korea: Is It Possible Within a Limited Time?
por: Elizee, Pegah Karimi, et al.
Publicado: (2012)

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy
por: Daram, Maryam, et al.
Publicado: (2014)

Prevalence of Hepatitis Delta Virus (HDV) Infection in Chronic Hepatitis B Patients with Unusual Clinical Pictures
por: Ghamari, Shiva, et al.
Publicado: (2013)

Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?
por: Khosravi, Mohammad Hossein, et al.
Publicado: (2016)

High Rate of Virological Response to Peginterferon α-2a–Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C
por: Alavi Moghaddam, Mostafa, et al.
Publicado: (2012)

How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study
por: Poortahmasebi, Vahdat, et al.
Publicado: (2016)

Art and viral hepatitis elimination programmes
por: Nima, Maryam, et al.
Publicado: (2018)

Celiac Disease and Abnormal Liver Function Test
por: Nejad, Mohammad Rostami, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ehl4p1l34ibpqp7emgeipk3ml9